Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium: Two paradoxes revisited

Circulation

Volumn 96, Issue 1, 1997, Pages 29-32

  Cleveland Jr , Joseph C ^a   Meldrum, Daniel R ^a   Cain, Brian S ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Diabetes mellitus; Ischemia; Pharmacology

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL BLOCKING AGENT; GLIBENCLAMIDE; GLIPIZIDE; INSULIN; ISOSORBIDE; ORAL ANTIDIABETIC AGENT; POTASSIUM; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FORCE; HEART MUSCLE; HUMAN; HUMAN TISSUE; ISCHEMIA; LONG TERM EXPOSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTECTION; RISK;

EID: 0030842472     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.1.29     Document Type: Article

References (15)

1. Klimt CR, Knatterud GL, Meinert CL, Prout TE (UDGP). A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes. 1970;19:747-830.
2. Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care. 1985;8:230-234.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
4. 1-adrenergic mechanism. Circ Res. 1993;73:656-670.
5. Shiki K, Hearse D. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol. 1987;253:H1470-H1476.
6. + channel? Circ Res. 1995;77:1030-1035.
7. Walker D, Walker J, Pugsley W, Pattison C, Yellon D. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 1995;27:1349-1357.
8. Cleveland JC, Wollmering MM, Meldrum DR, Rowland RT, Rehring TF, Sheridan BC, Harken AH, Banerjee A. Ischemic preconditioning of human and rat ventricle. Am J Physiol. 1996;271: H1786-H1794.
9. Kloner R, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson SM, Poole WK. Previous angina alters in-hospital outcome in TIMI 4. Circulation. 1995;91:37-47.
10. Deutsch E, Berger M, Kussmaul W, Hirshfeld J, Herrmann H, Laskey W. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation. 1990;82:2044-2051.
11. Yellon D, Alkhulaifi A, Pugsley W. Preconditioning the human myocardium. Lancet. 1993;342:276-277.
12. + channel blocker. Circulation. 1994;90:700-705.
13. ATP blockade in type II diabetes and preconditioning in cardiovascular diseases. Circulation. 1996; 94:2297-2301.
14. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223-233.
15. + channels. J Biol Chem. 1988;263:7933-7936.